Causal effects of lipid-lowering drug targets on psychiatric disorders: A drug-target Mendelian randomization study. [PDF]
Wang Y, Liu X, Huang S.
europepmc +1 more source
Increasing recognition of statin-associated anti-HMGCR antibody-positive autoimmune myopathy: a single-center retrospective study. [PDF]
Mali M +4 more
europepmc +1 more source
Repurposing statins for the treatment of larval cestodiases: <i>in silico</i> evaluation of statin-HMG-CoA reductase interactions and assessment of statin effects on a cestode model. [PDF]
Monteiro Guedes M +8 more
europepmc +1 more source
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults—Authors’ reply [PDF]
B, Pertzov +5 more
openaire +2 more sources
Computational Evaluation of Statin Analogs Targeting HMG-CoA Reductase for Coronary Artery Disease Treatment. [PDF]
Mtulo YB +4 more
europepmc +1 more source
Hydroxymethylglutaryl CoA Reductase
openaire +2 more sources
Genetic Biomarkers for Statin-Induced Myopathy. [PDF]
Prieto-Peña D +10 more
europepmc +1 more source
Statins and hemorrhagic stroke: New insight from a Mendelian randomization study. [PDF]
Gu X, Du X, Yao Z, Gu S.
europepmc +1 more source
Beyond the Generalized Weakness: A Rare Case of Statin-Induced Immune-Mediated Necrotizing Myopathy. [PDF]
Sakai L, Kazbour H, Huang J.
europepmc +1 more source
Lipid, lipid-lowering drugs, and bleedings: A Mendelian randomization and retrospective study. [PDF]
Guo S, Hu S, Chen H, Chen KY.
europepmc +1 more source

